Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Autoimmune disease and subsequent urological cancer.

Liu X, Ji J, Forsti A, Sundquist K, Sundquist J, Hemminki K.

J Urol. 2013 Jun;189(6):2262-8. doi: 10.1016/j.juro.2012.12.014. Epub 2012 Dec 8.

PMID:
23228387
2.

Effect of autoimmune diseases on risk and survival in female cancers.

Hemminki K, Liu X, Ji J, Försti A, Sundquist J, Sundquist K.

Gynecol Oncol. 2012 Oct;127(1):180-5. doi: 10.1016/j.ygyno.2012.07.100. Epub 2012 Jul 20.

PMID:
22819787
3.

Effect of autoimmune diseases on risk and survival in histology-specific lung cancer.

Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K.

Eur Respir J. 2012 Dec;40(6):1489-95. doi: 10.1183/09031936.00222911. Epub 2012 Feb 9.

4.

Risk of urinary tract cancers following kidney or ureter stones.

Chow WH, Lindblad P, Gridley G, Nyrén O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni JF Jr.

J Natl Cancer Inst. 1997 Oct 1;89(19):1453-7.

PMID:
9326915
5.

Survey of incidence of urological cancer in South Korea: a 15-year summary.

Cheon J, Kim CS, Lee ES, Hong SJ, Cho YH, Shin EC, Lee WC, Yoon MS.

Int J Urol. 2002 Aug;9(8):445-54.

6.

The impact of obesity on overall and cancer specific survival in men with prostate cancer.

Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR.

J Urol. 2009 Jul;182(1):112-7; discussion 117. doi: 10.1016/j.juro.2009.02.118. Epub 2009 May 17.

PMID:
19447437
7.

Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.

Saito K, Kihara K.

Int J Urol. 2013 Feb;20(2):161-71. doi: 10.1111/j.1442-2042.2012.03121.x. Epub 2012 Aug 16. Review.

8.

Familial risk of urological cancers: data for clinical counseling.

Hemminki K, Li X, Czene K.

World J Urol. 2004 Feb;21(6):377-81. Epub 2003 Nov 13.

PMID:
14615900
9.

Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.

Engholm G, Hakulinen T, Gislum M, Tryggvadóttir L, Klint A, Bray F, Storm HH.

Acta Oncol. 2010 Jun;49(5):655-64. doi: 10.3109/02841860903575299.

PMID:
20156116
10.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
11.

Increasing occurrence of urological cancers in Slovakia.

Plesko I, Obsitnikova A, Cuninkova M, Tomasek L, Stefanakova D, Kubik A.

Neoplasma. 2004;51(4):248-54.

PMID:
15254654
12.

Gout patients have an increased risk of developing most cancers, especially urological cancers.

Chen CJ, Yen JH, Chang SJ.

Scand J Rheumatol. 2014;43(5):385-90. doi: 10.3109/03009742.2013.878387. Epub 2014 May 14.

PMID:
24825466
13.

[De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].

di Capua Sacoto C, Luján Marco S, Bahilo Mateu P, Budía Alba A, Pontones Moreno JL, Jiménez Cruz JF.

Actas Urol Esp. 2010 Jan;34(1):88-94. Spanish.

PMID:
20223138
14.

Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.

Mathers MJ, Zumbe J, Wyler S, Roth S, Gerken M, Hofstädter F, Klotz T.

World J Urol. 2008 Jun;26(3):251-6. doi: 10.1007/s00345-008-0244-5. Epub 2008 Apr 18.

PMID:
18421461
15.

Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.

Bratt O, Garmo H, Adolfsson J, Bill-Axelson A, Holmberg L, Lambe M, Stattin P.

J Natl Cancer Inst. 2010 Sep 8;102(17):1336-43. doi: 10.1093/jnci/djq265. Epub 2010 Aug 19.

PMID:
20724726
16.

Double primary cancers of the prostate and bladder: a literature review.

Kinoshita Y, Singh A, Rovito PM Jr, Wang CY, Haas GP.

Clin Prostate Cancer. 2004 Sep;3(2):83-6. Review.

PMID:
15479490
17.

A systematic review of the epidemiological literature on the risk of urological cancers in systemic lupus erythematosus.

Huang HB, Jiang SC, Han J, Cheng QS, Dong CB, Pan CM.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1067-73. doi: 10.1007/s00432-014-1604-8. Epub 2014 Feb 14. Review.

PMID:
24525705
18.

Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?

Hemminki K, Li X, Sundquist J, Sundquist K.

Ann Epidemiol. 2010 Mar;20(3):217-22. doi: 10.1016/j.annepidem.2009.11.007. Epub 2009 Dec 29.

PMID:
20036578
19.

Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.

Castro FA, Liu X, Försti A, Ji J, Sundquist J, Sundquist K, Koshiol J, Hemminki K.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):1038-45.e7. doi: 10.1016/j.cgh.2013.11.007. Epub 2013 Nov 15.

PMID:
24246767
20.

Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.

Fairey AS, Jacobsen NE, Chetner MP, Mador DR, Metcalfe JB, Moore RB, Rourke KF, Todd GT, Venner PM, Voaklander DC, Estey EP.

J Urol. 2009 Jul;182(1):85-92; discussion 93. doi: 10.1016/j.juro.2008.11.111. Epub 2009 May 17.

PMID:
19447413

Supplemental Content

Support Center